These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 785427)

  • 1. An adsorbed surface-antigen influenza vaccine and its serological activity in volunteers.
    Brady MI; Furminger IG; Stones PB
    Postgrad Med J; 1976 Jun; 52(608):368-72. PubMed ID: 785427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters.
    Jennings R; Potter CW; McLaren C; Brady M
    J Hyg (Lond); 1975 Dec; 75(3):341-52. PubMed ID: 1059704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group.
    Potter CW; Jennings R; McLaren C; Edey D; Stuart-Harris CH; Brady M
    J Hyg (Lond); 1975 Dec; 75(3):353-62. PubMed ID: 1059705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine.
    Laver WG; Webster RG
    Postgrad Med J; 1976 Jun; 52(608):373-8. PubMed ID: 785428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological response to an adsorbed killed trivalent influenza vaccine (including A/New Jersey 8/76 antigen).
    Sarateanu D; Ehrengut W; Pressler K
    Dev Biol Stand; 1977 Jun 1-3; 39():235-8. PubMed ID: 604102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of antineuraminidase antibodies and antihemagglutinins in influenza and following administration of live influenza vaccine].
    Nekliudova LI; Fedorova IuB; Orlova NG
    Vopr Virusol; 1974; (2):173-6. PubMed ID: 4446555
    [No Abstract]   [Full Text] [Related]  

  • 7. [Formation and protective functions of antibodies to neuraminidase of the influenza A virus].
    Naĭkhin AN; Tsaritsyna IM; Oleĭnikova EV; Ismagulov AT; Reznik VI
    Vopr Virusol; 1985; 30(1):35-9. PubMed ID: 3993000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and properties of a novel influenza subunit vaccine.
    Bachmayer H; Liehl E; Schmidt G
    Postgrad Med J; 1976 Jun; 52(608):360-7. PubMed ID: 959116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses.
    Hassantoufighi A; Zhang H; Sandbulte M; Gao J; Manischewitz J; King L; Golding H; Straight TM; Eichelberger MC
    Vaccine; 2010 Jan; 28(3):790-7. PubMed ID: 19887135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the antigenicity of influenza virus aluminum oxide adjuvant vaccine "Alorbat" in man (author's transl)].
    Desselberger U; Pressler K; Erdmann G
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):160-77. PubMed ID: 1179878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials with a new influenza subunit vaccine in adults and children.
    Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
    Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Formation and persistence of antibodies against envelope antigens of influenza virus after vaccination by formolized monovaccine (author's transl)].
    Stumpa A; Bruj J; Tůmová B; Skocil V
    Cesk Epidemiol Mikrobiol Imunol; 1978 Feb; 27(1):29-37. PubMed ID: 149598
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influenza vaccination: antibodies against hemagglutinin and neuraminidase after administration of common Al2O3 and Al(OH)3 vaccines in man].
    Kuwert E; Schoop HJ; Marcus I
    Verh Dtsch Ges Inn Med; 1973; 79():1429-33. PubMed ID: 4790204
    [No Abstract]   [Full Text] [Related]  

  • 15. Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines.
    Xu K; Li C; Gravel C; Jiang Z; Jaentschke B; Van Domselaar G; Li X; Wang J
    Sci Rep; 2018 Jan; 8(1):1067. PubMed ID: 29348625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner.
    Sambhara V
    J Infect Dis; 2011 Jun; 203(11):1697-8. PubMed ID: 21593002
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
    Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
    Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postvaccinal anti-influenza immunity and its determining factors].
    Kastrikina LN; Lonskaia NI
    Vopr Virusol; 1990; 35(5):362-7. PubMed ID: 2267774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.